Body Composition Methods in Adults with Type 2 Diabetes or at Risk for T2D: a Clinical Review

被引:15
|
作者
Sneed, Nadia Markie [1 ]
Morrison, Shannon A. [2 ]
机构
[1] Univ Alabama Birmingham, Sch Nursing Off Res & Scholarship, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Nursing, Dept Family Community Hlth & Syst, Birmingham, AL USA
关键词
Body composition; Type 2 diabetes risk; Type; 2; diabetes; Prediabetes; Clinical review; HOMEOSTASIS MODEL ASSESSMENT; ADIPOSE-TISSUE DISTRIBUTION; INSULIN-RESISTANCE; CARDIOMETABOLIC RISK; CONSENSUS STATEMENT; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; ABDOMINAL FAT; OLDER-ADULTS; MUSCLE MASS;
D O I
10.1007/s11892-021-01381-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewThe aim of this study is to summarize anthropometric and advanced methods used to assess body composition in adults diagnosed with type 2 diabetes (T2D) or at risk for T2D that provide clinically relevant information about T2D disease-related complications or risk factors.Recent FindingsAnthropometry is commonly used in clinical settings; however, provides unreliable estimates of fat mass, fat-free mass, and body fat distribution for metabolic health assessments compared to advanced techniques such as bioelectrical impedance analysis (BIA), dual-energy x-ray absorptiometry (DXA), computerized tomography (CT), and magnetic resonance imaging (MRI). Few studies report the clinical use of anthropometric and advanced body composition methods that identify T2D disease-related complications or T2D risk factors.SummaryAnthropometry, BIA, DXA, CT, and MRI were used to estimate body adiposity and distribution, visceral and subcutaneous adipose tissue depots, and skeletal muscle mass. Review findings indicate that these methods were capable of identifying clinically relevant T2D disease-related complications such as sarcopenia and T2D risk factors such as obesity or regional adiposity. However, estimates were often sex and race/ethnicity specific warranting cross-validation of these methods in broader populations with T2D or risk for T2D prior to clinical implementation.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Clonal Hematopoiesis of Indeterminate Potential (CHIP), Glycemic Traits, and Type 2 Diabetes (T2D) Risk
    Tobias, Deirdre K.
    Manning, Alisa
    Wessel, Jennifer
    Westerman, Kenneth E.
    Raghavan, Sridharan
    Raffield, Laura
    Dupuis, Josee
    Bick, Alexander
    Wu, Peitao
    Dicorpo, Daniel A.
    Psaty, Bruce M.
    Morrison, Alanna C.
    Ramachandran, Vasan S.
    Adrienne Cupples, L.
    Lange, Leslie
    Correa, Adolfo
    Kooperberg, Charles L.
    Tinker, Lesley F.
    Howard, Barbara V.
    Reiner, Alex
    Rotter, Jerome I.
    Collins, Jason M.
    Meigs, James B.
    Manson, Joann E.
    DIABETES, 2021, 70
  • [32] Sex differences in the influence of type 2 diabetes (T2D)-related genes, parental history of T2D, and obesity on T2D development: a case-control study
    Berumen, Jaime
    Orozco, Lorena
    Gallardo-Rincon, Hector
    Rivas, Fernando
    Barrera, Elizabeth
    Benuto, Rosa E.
    Garcia-Ortiz, Humberto
    Marin-Medina, Melissa
    Juarez-Torres, Eligia
    Alvarado-Silva, Anabel
    Ramos-Martinez, Espiridion
    Martinez-Juarez, Luis Alberto
    Lomelin-Gascon, Julieta
    Montoya, Alejandra
    Ortega-Montiel, Janinne
    Alvarez-Hernandez, Diego-Abelardo
    Larriva-Shad, Jorge
    Tapia-Conyer, Roberto
    BIOLOGY OF SEX DIFFERENCES, 2023, 14 (01)
  • [33] NEW TECHNOLOGIES IN TYPE 2 DIABETES (T2D) MANAGEMENT AND FUTURE OPPORTUNITIES TO IMPROVE CLINICAL OUTCOMES
    Edelman, S.
    Kerr, D.
    Khunti, K.
    Vespasiani, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A46 - A47
  • [34] Findings at Diagnosis of Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D): The Pediatric Diabetes Consortium (PDC)
    Klingensmith, Georgeanna J.
    Willi, Steven M.
    Cengiz, Eda
    Wood, Jamie
    Tamborlane, William V.
    Lee, Joyce M.
    Haro, Heidi
    Beck, Roy W.
    Kollman, Craig
    Ruedy, Katrina
    Connor, Crystal
    DIABETES, 2014, 63 : A391 - A391
  • [35] Perception of Risk for Developing Type 2 Diabetes (T2D) among Women With Recent Gestational Diabetes Mellitus (GDM)
    Lawrence, Jean M.
    Donahoo, William T.
    Raebel, Marsha A.
    Desai, Jay
    Ferrara, Assiamira
    Bennett, Wendy T.
    Zhang, Jian L.
    Newton, Katherine M.
    DIABETES, 2013, 62 : A359 - A359
  • [36] Dietary Patterns in Diverse Adults with Type 2 Diabetes (T2D) : Self-Efficacy and Personal Control
    Mendez-Rodriguez, Heidy
    Jonas, Victoria H.
    Pappalardo, Lindsey D.
    Fang, Ran
    Schechter, Clyde
    Walker, Elizabeth A.
    Hoogendoorn, Claire J.
    Gonzalez, Jeffrey S.
    DIABETES, 2022, 71
  • [37] Weight Loss Strategies and Changes in Body Weight among Subjects with Type 2 Diabetes (T2D) in the US
    Wang, Yiting
    Lopez, Janice
    Zhu, Vivienne
    Bolge, Susan C.
    Rupnow, Marcia
    Bailey, Robert A.
    Stang, Paul E.
    DIABETES, 2015, 64 : A429 - A429
  • [38] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes (T2D): Outcomes by Body Mass Index (BMI)
    Shatskov, Alla
    Rezvani, Geoffrey
    Mansfield, Traci
    DIABETES, 2016, 65 : A299 - A299
  • [39] Factors Associated with Choice of Incretin-Based Medication Class in Adults with Type 2 Diabetes (T2D)
    Mehta, Sanjeev N.
    Niewczas, Monika A.
    McMullen, William J.
    Gruener, Alf H.
    Doria, Alessandro
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [40] Challenges to Effective Self-Management of Type 2 Diabetes (T2D) in Adults: Results of a Phenomenological Study
    Teixeira, Mary Elizabeth
    NURSING RESEARCH, 2017, 66 (02) : E94 - E94